Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Barberis

Showing results (51-60 of 169) with videos related to

Pageof 17
Sort By:
Expert Review of Respiratory Medicine|January 15, 2019
Diagnosis and first-line treatment of non-small cell lung cancer in the era of novel immunotherapy: recommendations for clinical practiceFilippo De Marinis, Massimo Barberis, Vito Barbieri, et al.
Journal of the National Cancer Institute. Monographs|June 12, 2015
Neoadjuvant Model in Cancer Treatment: From Clinical Opportunity to Health-Care UtilityDaniele Generali, Stephen B Fox, Massimo Cristofanilli, et al.
European Radiology|August 25, 2017
Metastatic and non-metastatic lymph nodes: quantification and different distribution of iodine uptake assessed by dual-energy CTStefania Rizzo, Davide Radice, Marco Femia, et al.
International Journal of Cancer|June 3, 2016
Prognostic significance of hematological profiles in melanoma patientsSara Gandini, Pier Francesco Ferrucci, Edoardo Botteri, et al.
Tumori|December 12, 2013
A case of NUT midline carcinoma with no HPV infection, slight EWSR1 rearrangement and strong expression of EGFRFausto Maffini, Christopher Alexander French, Michael James Cameron, et al.
Lung Cancer (Amsterdam, Netherlands)|July 2, 2013
EGFR tyrosine kinase inhibitors beyond focal progression obtain a prolonged disease control in patients with advanced adenocarcinoma of the lungFabio Conforti, Chiara Catania, Francesca Toffalorio, et al.
Cancers|May 5, 2021
Genomic Characterization of Concurrent Alterations in Non-Small Cell Lung Cancer (NSCLC) Harboring Actionable MutationsAntonio Passaro, Ilaria Attili, Alessandra Rappa, et al.
Neuroendocrinology|May 1, 2015
Temozolomide in Advanced Neuroendocrine Neoplasms: Pharmacological and Clinical AspectsAnna Koumarianou, Gregory Kaltsas, Matthew H Kulke, et al.
Breast Cancer Research and Treatment|January 10, 2012
Methylation of O6-methylguanine-DNA methyltransferase (MGMT) promoter gene in triple-negative breast cancer patientsCaterina Fumagalli, Giancarlo Pruneri, Paola Possanzini, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 16, 2011
Activity of epidermal growth factor receptor-tyrosine kinase inhibitors in patients with non-small cell lung cancer harboring rare epidermal growth factor receptor mutationsTommaso De Pas, Francesca Toffalorio, Michela Manzotti, et al.
Pageof 17

Showing results (51-60 of 169) with videos related to

Sort By:
Pageof 17
Expert Review of Respiratory Medicine|January 15, 2019
Diagnosis and first-line treatment of non-small cell lung cancer in the era of novel immunotherapy: recommendations for clinical practiceFilippo De Marinis, Massimo Barberis, Vito Barbieri, et al.
Journal of the National Cancer Institute. Monographs|June 12, 2015
Neoadjuvant Model in Cancer Treatment: From Clinical Opportunity to Health-Care UtilityDaniele Generali, Stephen B Fox, Massimo Cristofanilli, et al.
European Radiology|August 25, 2017
Metastatic and non-metastatic lymph nodes: quantification and different distribution of iodine uptake assessed by dual-energy CTStefania Rizzo, Davide Radice, Marco Femia, et al.
International Journal of Cancer|June 3, 2016
Prognostic significance of hematological profiles in melanoma patientsSara Gandini, Pier Francesco Ferrucci, Edoardo Botteri, et al.
Tumori|December 12, 2013
A case of NUT midline carcinoma with no HPV infection, slight EWSR1 rearrangement and strong expression of EGFRFausto Maffini, Christopher Alexander French, Michael James Cameron, et al.
Lung Cancer (Amsterdam, Netherlands)|July 2, 2013
EGFR tyrosine kinase inhibitors beyond focal progression obtain a prolonged disease control in patients with advanced adenocarcinoma of the lungFabio Conforti, Chiara Catania, Francesca Toffalorio, et al.
Cancers|May 5, 2021
Genomic Characterization of Concurrent Alterations in Non-Small Cell Lung Cancer (NSCLC) Harboring Actionable MutationsAntonio Passaro, Ilaria Attili, Alessandra Rappa, et al.
Neuroendocrinology|May 1, 2015
Temozolomide in Advanced Neuroendocrine Neoplasms: Pharmacological and Clinical AspectsAnna Koumarianou, Gregory Kaltsas, Matthew H Kulke, et al.
Breast Cancer Research and Treatment|January 10, 2012
Methylation of O6-methylguanine-DNA methyltransferase (MGMT) promoter gene in triple-negative breast cancer patientsCaterina Fumagalli, Giancarlo Pruneri, Paola Possanzini, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 16, 2011
Activity of epidermal growth factor receptor-tyrosine kinase inhibitors in patients with non-small cell lung cancer harboring rare epidermal growth factor receptor mutationsTommaso De Pas, Francesca Toffalorio, Michela Manzotti, et al.
Pageof 17